About
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap5,355 Cr
P/E110.00
Div Yield0.16 %
Book Value—
52w High₹479.00
52w Low₹225.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Jun 2025 |
|---|---|---|---|
| Sales | 44.00 | 44.00 | 36.00 |
| Expenses | 23.00 | 25.00 | 22.00 |
| Operating Profit | 21.00 | 19.00 | 14.00 |
| OPM % | 48.00 | 44.00 | 39.00 |
| Other Income | 0.00 | 1.00 | 0.00 |
| Depreciation | 4.00 | 4.00 | 2.00 |
| Interest | 2.00 | 2.00 | 0.00 |
| Profit before tax | 15.00 | 14.00 | 12.00 |
| Tax % | 27.00 | 24.00 | 25.00 |
| Net Profit | 11.00 | 11.00 | 9.00 |
| EPS in Rs | 1.02 | 1.00 | 0.83 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 |
|---|---|
| Sales | 166.00 |
| Expenses | 90.00 |
| Operating Profit | 76.00 |
| OPM % | 46.00 |
| Other Income | 2.00 |
| Interest | 3.00 |
| Depreciation | 13.00 |
| Profit before tax | 62.00 |
| Tax % | 25.00 |
| Net Profit | 47.00 |
| EPS in Rs | 4.28 |
| Dividend Payout % | 0.00 |
Corporate Actions
12 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 04 Sep 2025 | 05 Sep 2025 | — | 0.67 | |
| Bonus | 09 Aug 2024 | 09 Aug 2024 | 1:2 | — | |
| Dividend | 15 Jul 2024 | — | — | 0.25 | |
| Dividend | 22 Feb 2024 | 22 Feb 2024 | — | 0.75 | |
| Split | 10 Oct 2023 | 10 Oct 2023 | 5:1 | — | |
| Dividend | 01 Sep 2023 | — | — | 1.00 | |
| Dividend | 02 Dec 2022 | 02 Dec 2022 | — | 4.40 | |
| Dividend | 29 Aug 2022 | — | — | 4.00 | |
| Dividend | 24 Nov 2021 | 25 Nov 2021 | — | 5.00 | |
| Dividend | 24 Nov 2021 | 25 Nov 2021 | — | 2.00 | |
| Dividend | 10 Sep 2020 | — | — | 1.65 | |
| Other | 07 Jun 2012 | 08 Jun 2012 | — | — | Reduction of Capital |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update15 Jul from care
-
Rating update18 Feb from care
-
Rating update25 Jun 2025 from care
-
Rating update19 May 2025 from care
-
Rating update22 Nov 2024 from care
-
Rating update7 Oct 2024 from care